Filing Details

Accession Number:
0001209191-20-052400
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-29 20:07:38
Reporting Period:
2020-09-29
Accepted Time:
2020-09-29 20:07:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1678660 Prelude Therapeutics Inc PRLD Pharmaceutical Preparations (2834) 811384762
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1824631 Christopher Pierce C/O Prelude Therapeutics Incorporated
200 Powder Mill Road
Wilmington DE 19801
Evp And Chief Of Business Oper No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-09-29 3,750 $19.00 3,750 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct